Ignite Creation Date:
2025-12-25 @ 12:03 AM
Ignite Modification Date:
2026-01-31 @ 4:59 AM
Study NCT ID:
NCT02222558
Status:
COMPLETED
Last Update Posted:
2016-05-30
First Post:
2014-08-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Oral Testosterone for the Treatment of Hypogonadism in Males
Sponsor:
TesoRx Pharma, LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TT-006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None